Deutsche Bank Ag\ Verona Pharma PLC Transaction History

Deutsche Bank Ag\

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$3.91 - $7.08 $230 - $417	-59 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$5.29 - $6.35 $5 - $6	1 Added 1.72%	59 $0
Q2 2021 Aug 11, 2021	BUY	$5.72 - $9.09 $331 - $527	58 New	58 $0
Q1 2021 May 13, 2021	SELL	$7.08 - $9.33 $828 - $1,091	-117 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$5.51 - $8.11 $644 - $948	117 New	117 $1,000
Q1 2020 May 14, 2020	SELL	$2.16 - $7.28 $954 - $3,217	-442 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.7 - $6.58 $251 - $447	68 Added 18.18%	442 $2,000
Q3 2019 Nov 14, 2019	SELL	$4.03 - $5.44 $39,897 - $53,856	-9,900 Reduced 96.36%	374 $1,000
Q2 2019 Aug 14, 2019	SELL	$5.1 - $6.91 $7,139 - $9,674	-1,400 Reduced 11.99%	10,274 $52,000
Q1 2019 May 15, 2019	BUY	$5.52 - $10.0 $30,359 - $55,000	5,500 Added 89.08%	11,674 $75,000
Q4 2018 Feb 14, 2019	SELL	$9.0 - $13.47 $2,187 - $3,273	-243 Reduced 3.79%	6,174 $55,000
Q3 2018 Nov 14, 2018	SELL	$11.65 - $14.1 $582 - $705	-50 Reduced 0.77%	6,417 $80,000
Q2 2018 Aug 14, 2018	BUY	$13.66 - $21.0 $65,103 - $100,086	4,766 Added 280.19%	6,467 $88,000
Q1 2018 May 15, 2018	BUY	$11.69 - $20.97 $12,870 - $23,087	1,101 Added 183.5%	1,701 $34,000
Q4 2017 Feb 14, 2018	BUY	$10.8 - $15.75 $6,480 - $9,450	600	600 $7,000

166

68.7M

704K

685K

Ticker VRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,954,200
Market Cap $2.17B
Description
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.